Empagliflozin reduces albuminuria: a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

Rikke Borg, Frederik Persson

Publikation: Bidrag til tidsskrift › Leder › Forskning

1 Citationer (Scopus)

120 Downloads (Pure)

Originalsprog	Engelsk
Artikelnummer	478
Tidsskrift	Journal of Translational Medicine
Vol/bind	5
Udgave nummer	23
Antal sider	4
ISSN	2305-5839
DOI	https://doi.org/10.21037/atm.2017.11.02
Status	Udgivet - 2017

Adgang til dokumentet

@article{82e2e6a7c7fb47ef80f63ba66f30fb0c,

title = "Empagliflozin reduces albuminuria: a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial",

author = "Rikke Borg and Frederik Persson",

year = "2017",

doi = "10.21037/atm.2017.11.02",

language = "English",

volume = "5",

journal = "Journal of Translational Medicine",

issn = "1479-5876",

publisher = "BioMed Central",

number = "23",

}

TY - JOUR

T1 - Empagliflozin reduces albuminuria

T2 - a promise for better cardiorenal protection from the EMPA-REG OUTCOME trial

AU - Borg, Rikke

AU - Persson, Frederik

PY - 2017

Y1 - 2017

U2 - 10.21037/atm.2017.11.02

DO - 10.21037/atm.2017.11.02

M3 - Editorial

C2 - 29285511

VL - 5

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 23

M1 - 478

ER -